Founded in 2014, Brinton Pharmaceuticals operates in Health Tech offering safe, economical and innovative medical solutions to meet the lifelong demands of people. The company is committed to supporti...
Funding stage:
Debt Financing
Last funding:
15/09/2020
Total funding:
$13.36 Mn+
Revenue:
Investors
Employee count:
735
Last 90d
735
Last 90d
Web traffic:
18.44K
18.44K
Last 30d
Last 30d
Glassdoor Rating:
Brinton Pharmaceuticals: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders16
Latest Filing Date29 April 2024- Funding Events24
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Brinton Pharmaceuticals
As of 30 April 2024, Brinton Pharmaceuticals's equity is held by 15 shareholders, with the top three being Rahul Kundanmal Darda, Beta TC Holdings Pte Ltd, and India Alternatives Private Equity.
Rahul Kundanmal Darda holds the largest stake in Brinton Pharmaceuticals at 51.2% as of 30 April 2024.
As of 30 April 2024, founders collectively hold 51.2% equity in Brinton Pharmaceuticals.
As of 30 April 2024, investors collectively hold 37.0% equity in Brinton Pharmaceuticals.
Brinton Pharmaceuticals's ESOP pool stands at 4.1% of total equity as of 30 April 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links